INOZYME PHARMA INC. -
5.2100
07-أكتوبر-24 14:59:31
15 متأخرة بدقائق
الأسهم
+0.0400
+0.77%
نطاق اليوم
5.1200 - 5.2800
ISIN
N/A
المصدر
NASDAQ
-
Inozyme Pharma to Participate in Upcoming Investor Conferences
09 نوفمبر 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights
07 نوفمبر 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 نوفمبر 2023 15:15:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Announces Presentation at the American Society of Nephrology (ASN) Kidney Week 2023
26 أكتوبر 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
10 أكتوبر 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
06 أكتوبر 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
26 سبتمبر 2023 06:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma to Host Virtual Investor and Analyst Event on Sep. 26, 2023
20 سبتمبر 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 سبتمبر 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma to Present at the H.C. Wainwright 25th Annual Global Investment Conference
05 سبتمبر 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Second Quarter 2023 Financial Results and Provides Business Highlights
08 أغسطس 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 أغسطس 2023 15:01:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma, Inc. Announces Closing of Public Offering of Common Stock
01 أغسطس 2023 15:01:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock
27 يوليو 2023 22:20:15 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma, Inc. Announces Proposed Offering of Common Stock
27 يوليو 2023 15:33:08 بحسب Nasdaq GlobeNewswire
-
26 يوليو 2023 06:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma to Provide ENPP1 Deficiency Program Update on July 26, 2023
19 يوليو 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Announces Dosing of First Infant with ENPP1 Deficiency in a Phase 1b Trial of INZ-701
27 يونيو 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma to Present at the Jefferies Healthcare Conference
02 يونيو 2023 06:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports First Quarter 2023 Financial Results and Provides Business Highlights
09 مايو 2023 07:30:00 بحسب Nasdaq GlobeNewswire